DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Bokemeyer C, Bondarenko I, Makhson A et al.
Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) versus FOLFOX-4 in the first-line treatment of metastatic colorectal cancer (mCRC): OPUS, a randomized phase II study.
Journal of Clinical Oncology 2007; ASCO Annual Meeting Proceedings Part I 2007
25 (Suppl. 18) 4035
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.